20 results
8-K
EX-99.2
TCRX
Tscan Therapeutics Inc
16 Apr 24
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities
4:16pm
sizable patient population, with several global and lifecycle management opportunities 20,000 Expansion opportunities in oncology and other 15,000
8-K
EX-99.2
TCRX
Tscan Therapeutics Inc
11 Dec 23
Regulation FD Disclosure
8:00am
Several global expansion and lifecycle management opportunities to address additional patient populations with significant unmet needs Non-malignant
10-K
e2s g7de9d6u
9 Mar 22
Annual report
7:30am
10-Q
kvnln 9lo
19 Aug 21
Quarterly report
7:31am
424B4
atsi25ixjtlrlri
19 Jul 21
Prospectus supplement with pricing info
7:01am
S-1/A
5aamghb
30 Apr 21
IPO registration (amended)
5:00pm
S-1
z5u7a
23 Apr 21
IPO registration
5:15pm
DRS
l53ugrmzndb a24
19 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next